Psychedelics Weekly – Psychedelics and Sports, The Risks of Over-Regulation, and...

COMPASS Pathways plc to announce first quarter 2023 financial results on...

The Top 5 Psychedelic Clinical Trials of 2022

Small Pharma to Present at Upcoming CINP World Congress of Neuropsychopharmacology

Psychedelics, The Brain, and the Future of Mental Health

atai Life Sciences to Participate in Upcoming May Investor Conference

Clearmind Medicine Announces Clinical Supply Agreement for its Upcoming Clinical Trial

PharmaTher Holdings Submits Fast Track Application to FDA for KETARX™ (Ketamine)...

PT408 – Fireside Project: Harm Reduction Through Free Peer Support

American Medical Association to Issue First New Code for Psychedelic Therapies

Load more